Medications

Botox developer rues missing out on billions

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Diseases, Conditions, Syndromes

On the cutting edge of laser eye surgery

Hindsight, unlike many people's vision, is always 20/20. Laser eye surgery has become so common, it's easy to forget that just three decades ago a promising new treatment was greeted with skepticism and even fear.

page 5 from 6